Through enhanced diagnostic, disease prevention and tailored treatments, personalized healthcare holds great promise for each of us. Research in this field was long hindered by technical, interoperability, ethical and legal challenges, which prevented access to a wealth of consented biomedical data from patients. SIB has played a key role in coordinating efforts on the national level, and establishing the Swiss infrastructure which is now boosting research in this field, in which over 20 of our groups are active. We are also part of several European public-private partnerships, several of which aiming to facilitate precision medicine in cancer or diabetes. Through outreach activities, we also inform the public about the promise and challenges of precision medicine and the role of bioinformatics to enable it.
Making sense of health data to guide treatment decisions
Joining EU-supported research consortium to improve obesity treatment
SIB is joining the international, public-private research consortium ‘SOPHIA’...
Understanding precision medicine with PrecisionMed.ch
While precision medicine is already a reality in the field of cancer treatment...
Bringing Swiss health data to biomedical research: an interoperability journey
Health data from patients are typically generated and stored in a multitude of...
Molecular big data, a new weapon for medicine
Being able to visualize the transmission of a virus in real-time during an...
"The network we are building to empower personalized health research will be here to last"
Personalized healthcare requires a solid foundation; establishing...
A national infrastructure network to enable secure biomedical data processing
Today, we present an overview of the BioMedIT project, coordinated by SIB’s...